Summary paper on the 2023 European Association of Urology guidelines on the management of non-neurogenic male lower urinary tract symptoms
Context Lower urinary tract symptoms (LUTS) are common, often bothersome, and have
multifactorial aetiology. Objective To present a summary of the 2023 version of the European …
multifactorial aetiology. Objective To present a summary of the 2023 version of the European …
EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction
Context Lower urinary tract symptoms (LUTS) represent one of the most common clinical
complaints in adult men and have multifactorial aetiology. Objective To develop European …
complaints in adult men and have multifactorial aetiology. Objective To develop European …
The mechanism of action of BCG therapy for bladder cancer—a current perspective
G Redelman-Sidi, MS Glickman, BH Bochner - Nature reviews urology, 2014 - nature.com
Abstract Bacillus Calmette–Guérin (BCG) has been used to treat non-muscle-invasive
bladder cancer for more than 30 years. It is one of the most successful biotherapies for …
bladder cancer for more than 30 years. It is one of the most successful biotherapies for …
Latest evidence on post-prostatectomy urinary incontinence
M Gacci, C De Nunzio, V Sakalis, M Rieken… - Journal of Clinical …, 2023 - mdpi.com
A radical prostatectomy is frequently used as the first-line treatment for men with prostate
cancer. Persistent urinary incontinence after surgery is one of the most severe adverse …
cancer. Persistent urinary incontinence after surgery is one of the most severe adverse …
[HTML][HTML] Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer
Abstract The International Consultations on Urological Diseases are international
consensus meetings, supported by the World Health Organization and the Union …
consensus meetings, supported by the World Health Organization and the Union …
[HTML][HTML] Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer …
W Kassouf, A Aprikian, P Black, G Kulkarni… - Canadian Urological …, 2016 - ncbi.nlm.nih.gov
This initiative was undertaken in response to concerns regarding the variation in
management and in outcomes of patients with bladder cancer throughout centres and …
management and in outcomes of patients with bladder cancer throughout centres and …
Alpha-2 Heremans Schmid Glycoprotein (AHSG) promotes the proliferation of bladder cancer cells by regulating the TGF-β signalling pathway
Y Dong, D Ding, J Gu, M Chen, S Li - Bioengineered, 2022 - Taylor & Francis
Bladder cancer (BC) is one of the most common urinary tract malignancies and is the tenth
most common cancer globally. Alpha-2 Heremans Schmid Glycoprotein (AHSG) is a …
most common cancer globally. Alpha-2 Heremans Schmid Glycoprotein (AHSG) is a …
Carcinoma in situ of the urinary bladder: a systematic review of current knowledge regarding detection, treatment, and outcomes
Context Carcinoma in situ (CIS) of the bladder is defined as a high-grade flat lesion confined
to the mucosa. Intravesical treatment with bacillus Calmette–Guérin (BCG) is commonly …
to the mucosa. Intravesical treatment with bacillus Calmette–Guérin (BCG) is commonly …
Prognostic implications of prostatic urethral involvement in non-muscle-invasive bladder cancer
A Brant, M Daniels, MR Chappidi, GA Joice… - World journal of …, 2019 - Springer
Purpose Non-muscle-invasive bladder cancer involving the prostatic urethra is associated
with pathologic upstaging and shorter survival. We investigated the survival impact of …
with pathologic upstaging and shorter survival. We investigated the survival impact of …
[HTML][HTML] Characteristics and survival of primary urothelial carcinoma of the prostate: A multi-center retrospective study of 18 cases
J Ji, T Liu, Y Yao, W Liu, H Ning, T Wang, G Zhang - Neoplasia, 2024 - Elsevier
Objectives To explore the features, treatment, and outcomes of primary urothelial carcinoma
of the prostate (PUCP) in a multicenter study. Methods The clinical and imaging features …
of the prostate (PUCP) in a multicenter study. Methods The clinical and imaging features …